Alzheimer’s disease is a devastating disorder affecting 6.2 million Americans. And many more millions are affected globally.
The purpose of this article is to introduce a drug named aducanumab branded as Aduhelm by Biogen in the United States. I aim to provide perspectives covering a broad range of thoughts and sentiments by professionals and the public as reflected in traditional and social media. Media sentiments demonstrate both celebration and apprehension. I wrote […]More